Asthma Prevalence and the Impact on Public Health: Insights from the CDC
The Importance of Indoor Air Quality Testing in Asthma Management
Introduction
Asthma continues to affect millions worldwide, with rates showing worrying increases across certain populations. A recent report from the U.S. Centers for Disease Control and Prevention (CDC) highlights just how significant the burden of asthma has become, and the wider economic and social impact it brings.
In this blog, we examine the key findings from the CDC’s data and explore why high-quality indoor air quality testing and monitoring ( a core service offered by Airmid Healthgroup) is essential in reducing asthma triggers and supporting healthier indoor environments.
Asthma Prevalence: What the CDC Found
The CDC report Asthma Prevalence, Health Care Use and Mortality: United States, 2005–2009 reveals stark statistics:
- The most rapid growth in asthma prevalence in the U.S. occurred between 1980 and 1996, rising from 3.5% to 5.5% of the population.
- Today, 8.2% of Americans—equivalent to 24.6 million people—live with asthma.
- Globally, it is estimated that 300 million people have some form of asthma symptoms, meaning the U.S. alone accounts for nearly 10% of cases worldwide.
When compared with European countries, the U.S. falls between Germany (4.7%, one of the lowest rates in Europe) and the UK (13.8%, one of the highest). Ireland also features among the countries with the greatest prevalence at 10.5%.
Demographic Disparities in Asthma Rates
The CDC’s analysis shows that asthma prevalence is not evenly distributed across populations:
- Socioeconomic factors: People with family incomes below the federal poverty level are more likely to have asthma.
- Ethnic and racial differences: Prevalence is higher among Black and Puerto Rican populations, and lower among Asian and Mexican populations.
- Gender differences: While boys aged 0–14 have higher asthma prevalence than girls, this trend reverses in adolescence and adulthood, where women show higher rates.
These disparities highlight the need for targeted interventions and better environmental management strategies.
The Broader Impact of Asthma
Asthma’s burden extends beyond health—it also affects education, employment, and economic productivity:
- In 2007, U.S. children missed 10.5 million school days due to asthma.
- Nearly 60% of respondents reported at least one asthma-related absence day in the previous year.
- Adults who experienced an asthma attack in the past year reported missing 14.2 million workdays—equivalent to 56,349 full-time workers absent for a year.
Such statistics make it clear: asthma is not only a personal health issue but a national economic challenge.
How Airmid Healthgroup Supports Asthma Management with Indoor Air Quality Testing
At Airmid Healthgroup, we specialize in indoor air quality testing and monitoring to help reduce exposure to allergens, pathogens, and chemical irritants that can exacerbate asthma. Our multidisciplinary team includes clinicians, industrial hygienists, and laboratory scientists working across allergy, immunology, mycology, virology, and bacteriology.
Our services include:
- Independent indoor air qualitytesting and verification of consumer products.
- Indoor air monitoring and consultancy for commercial and residential spaces.
- State-of-the-art laboratory research supporting product innovation.
By combining science with real-world applications, Airmid helps manufacturers, retailers, and organizations create environments that reduce exposure risks for people with asthma and allergies.
Indoor Air Quality Testing Services at Airmid Healthgroup
ISO 15714:2019 Bioaerosol Efficacy Testing for Air Treatment Devices
This standard outlines a controlled laboratory method for evaluating the antimicrobial performance of air treatment devices using aerosolized biological agents. It’s particularly relevant for products like air purifiers, HVAC-integrated filtration systems, and UV-C units. Testing according to ISO 15714:2019 provides quantitative evidence of a device’s effectiveness under controlled conditions, supporting product development, regulatory submissions, and marketing claims.
🔗 Learn more about ISO 15714:2019 testing
30m³ Environmental Test Chamber Services
The 30m³ Environmental Test Chamber, also known as the “George Stokes Chamber”, is custom-engineered for airborne pathogen and antimicrobial surface technology validation. Designed by aerobiologists and infection control experts, this chamber simulates real-world environments under precisely controlled conditions, making it ideal for testing air disinfection systems, filtration technologies, and cleaning protocols.
🔗 Learn about the 30m³ Environmental Test Chamber
Virology Laboratory Services
Airmid Healthgroup’s ISO/IEC 17025:2017-accredited Virology Laboratory offers advanced testing services to assess the efficacy of products against specific target viruses. Utilizing both proprietary and standardized methods, the lab evaluates prototype appliances, components, and finished products under simulated real-world conditions.
🔗 Explore Virology Laboratory Services
Related blogs
Inside Airmid’s State-of-the-Art Aerobiology Test Chambers
Environmental Test Chambers: Driving Product Innovation and Healthier Indoor Air
From Lab Bench to Loyalty: The People Powering Health-Focused Innovation
Word Tags
Indoor air quality testing, Asthma prevalence, CDC asthma report, Indoor air monitoring, Asthma triggers, Air quality and health, Allergy and asthma management, Indoor environmental testing, Public health and asthma, Airmid Healthgroup services
About iAIR Labs
Aerobiology Lab Testing for Airborne Pathogens, Infectious Aerosols & Antimicrobial Surfaces. Comprehensive Testing Services for Infectious Aerosols, Airborne Pathogens & Anti-Microbial Surface Technologies. Airmid Healthgroup is a world-leading contract research laboratory, accredited to ISO/IEC 17025:2017 by the Irish National Accreditation Board (INAB, Reg. No. 284T) for specific allergen testing methods, including cat (Fel d 1) and house dust mite (Dermatophagoides pteronyssinus, Der p 1), and is dedicated to safeguarding health in the built environment. From airborne pathogen testing and indoor air quality validation to antimicrobial surface and textile efficacy studies, we provide the independent data and scientific validation that innovators need to meet regulatory requirements, accelerate product development, and earn consumer confidence. Trusted globally by medtech, consumer product, and building technology leaders, our advanced bioaerosol chamber facilities and expertise in microbiology, virology, allergens and aerobiology enable real-world performance testing to the highest international standards, including: ASHRAE 241, AHAM, AC-5, ISO 16000, ISO 18184, and ASTM E3135.
